Ion Channel Companies

Since ion channels are commonly regarded as promising therapeutic targets, most big pharma companies as well as multiple biotech companies have/had at least one ion channel modulator in their pipeline. A number of other companies (e.g., CROs and manufacturers) propose their services/equipment to everybody involved in ion channel research and drug discovery.